490 results on '"Hawkins, Nathaniel M."'
Search Results
2. Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review
3. Validation of machine learning models for estimation of left ventricular ejection fraction on point-of-care ultrasound: insights on features that impact performance
4. Kidney function monitoring and trajectories in patients with atrial fibrillation
5. Qualitative Analysis of Patient Decisional Needs for Medications to Treat Heart Failure
6. Distinguishing Primary Prevention From Secondary Prevention Implantable Cardioverter Defibrillators Using Administrative Health and Cardiac Device Registry Data
7. Heart failure with preserved ejection fraction: everything the clinician needs to know
8. Sex Differences in High-Cost Users of Healthcare for Atrial Fibrillation
9. Navigating the Landscape of Medical Device Advisories: A Special Report From the Canadian Heart Rhythm Society Device Advisory Committee
10. Defining the gap in heart failure treatment in patients with cardiac implantable electronic devices
11. Access to Heart Failure Services in Canada: Findings of the Heart and Stroke National Heart Failure Resources and Services Inventory
12. Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial
13. Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure Hospitalization
14. Validation of a Case Definition to Identify Patients Diagnosed With Cardiovascular Disease in Canadian Primary Care Practices
15. MACE in COPD: addressing cardiopulmonary risk
16. Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry
17. Management of Atrial Tachyarrhythmias in Heart Failure—an Interventionalist’s Point of View
18. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
19. Cardiac Magnetic Resonance in the Evaluation of Patients With Frequent Premature Ventricular Complexes
20. Sex Differences in the Management of Oral Anticoagulation and Outcomes for Emergency Department Presentation of Incident Atrial Fibrillation
21. Chronic lung disease
22. The Introduction of Direct Oral Anticoagulants Has Not Resolved Treatment Gaps for Frail Patients With Nonvalvular Atrial Fibrillation
23. Heart failure treatment in patients with cardiac implantable electronic devices: Opportunity for improvement
24. Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: 2024 Status and Management Update
25. Electronic Health Record Alerts for Heart Failure
26. Evaluation of PHARM‐HF, a pharmacist‐led heart failure medication titration clinic: A pre‐post study
27. Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease
28. Predicting Catheter Ablation Outcomes with Pre-ablation Heart Rhythm Data: Less Is More
29. Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review
30. Effectiveness of a simple medication adjustment protocol for optimizing peri-cardioversion rate control: A derivation and validation cohort study
31. Driving Restrictions and Early Arrhythmias in Patients Receiving a Secondary Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD- II study)
32. Driving Restrictions and Early Arrhythmias in Patients Receiving a Primary-Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD) Study
33. Impact of Female Sex on Clinical Presentation and Ablation Outcomes in the CIRCA-DOSE Study
34. Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary care
35. Influence of Monitoring Strategy on Assessment of Ablation Success and Postablation Atrial Fibrillation Burden Assessment: Implications for Practice and Clinical Trial Design
36. Myocarditis and Pericarditis After mRNA COVID-19 Vaccination: 2024 Status and Management Update
37. The Relationship Between Heart-Failure Hospitalization and Mortality in Patients Receiving Transcatheter Aortic Valve Replacement
38. External Validation of the ABC-VT Risk Score for Patients With Frequent Ventricular Ectopy
39. Predicting Catheter Ablation Outcomes with Pre-ablation Heart Rhythm Data: Less Is More
40. Variability in Non–Vitamin K Antagonist Oral Anticoagulants Dose Adjustment in Atrial Fibrillation Patients With Renal Dysfunction: The Influence of Renal Function Estimation Formulae
41. Heart Failure in Young Adults Is Associated With High Mortality: A Contemporary Population-Level Analysis
42. EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies
43. Patient experiences of implantable cardiac monitoring in hypertrophic cardiomyopathy: an exploratory study.
44. Quality improvement initiative to optimize heart failure treatment in patients with cardiac implantable electronic devices
45. Renal Safety of de Novo Angiotensin-Neprilysin Inhibition in Older Adults: Insights From a Population-Based Analysis
46. Coronary angiography and myocardial revascularization following the first acute myocardial infarction in Norway during 2001–2009: Analyzing time trends and educational inequalities using data from the CVDNOR project
47. Review of Eligibility for Cardiac Resynchronization Therapy
48. Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study
49. Defining the gap in heart failure treatment in patients with cardiac implantable electronic devices
50. Shockingly shiny shoes—Inappropriate discharge from a subcutaneous defibrillator
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.